CreXus (CXS) is downgraded to Neutral from Overweight at JPMorgan after yesterday's purchase offer from Annaly took the stock above book value and nearly to the level of the acquisition price. If CreXus shareholders haven't sold yet, they may want to think about it as pretty much only bad things can happen to the stock price from here.
From other sites
at CNBC.com (Nov 12, 2012)
at CNBC.com (Jun 20, 2011)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs